Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy
- DOI
- 10.1111/all.70560
- Published
- 2026-11-09
- Container
- Allergy
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/all.70560,
title = {Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy},
author = {Letizia Ciliberti and Simona Barni and Claudia Valleriani and Lucrezia Sarti and Giulia Liccioli and Leonardo Tomei and Gabriele Simonetti and Francesco Catamerò and Mattia Giovannini and R. Sharon Chinthrajah and Francesca Mori},
year = {2026},
journal = {Allergy},
doi = {10.1111/all.70560},
url = {https://doi.org/10.1111/all.70560}
}RIS
TY - JOUR TI - Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy AU - Letizia Ciliberti AU - Simona Barni AU - Claudia Valleriani AU - Lucrezia Sarti AU - Giulia Liccioli AU - Leonardo Tomei AU - Gabriele Simonetti AU - Francesco Catamerò AU - Mattia Giovannini AU - R. Sharon Chinthrajah AU - Francesca Mori PY - 2026 JO - Allergy DO - 10.1111/all.70560 UR - https://doi.org/10.1111/all.70560 ER -
APA
Ciliberti, L., Barni, S., Valleriani, C., Sarti, L., Liccioli, G., Tomei, L., Simonetti, G., Catamerò, F., Giovannini, M., Chinthrajah, R. S., & Mori, F. (2026). Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy. Allergy. https://doi.org/10.1111/all.70560
Source records
- crossref · retrieved 2026-11-10T04:59:11.204Z